Libert(605167)
Search documents
利柏特(605167) - 第五届监事会第十五次会议决议公告
2025-06-30 09:45
1、本次发行证券的种类 一、监事会会议召开情况 江苏利柏特股份有限公司(以下简称"公司")第五届监事会第十五次会议 于 2025 年 6 月 30 日(星期一)在公司会议室以现场结合通讯的方式召开。全体 监事一致同意豁免本次会议通知期限要求。 本次会议应出席监事 3 人,实际出席监事 3 人。会议由监事会主席张英洁女 士主持,董事、高管列席。本次会议召开符合有关法律、行政法规、部门规章、 规范性文件和《公司章程》的规定。 二、监事会会议审议情况 (一)逐项审议通过《关于进一步明确公司向不特定对象发行可转换公司 债券方案的议案》 公司已收到中国证券监督管理委员会出具的《关于同意江苏利柏特股份有限 公司向不特定对象发行可转换公司债券注册的批复》(证监许可[2025]1173 号), 同意公司向不特定对象发行可转换公司债券(以下简称"本次发行")的注册申 请。公司根据2024年第一次临时股东大会及2024年第三次临时股东大会的授权, 以及相关法律、法规和规范性文件的规定,结合公司实际情况和市场状况,确定 了本次发行方案,具体情况如下: 证券代码:605167 证券简称:利柏特 公告编号:2025-021 江苏利柏特 ...
利柏特(605167) - 第五届董事会第十五次会议决议公告
2025-06-30 09:45
证券代码:605167 证券简称:利柏特 公告编号:2025-020 江苏利柏特股份有限公司 第五届董事会第十五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 江苏利柏特股份有限公司(以下简称"公司")第五届董事会第十五次会议 于 2025 年 6 月 30 日(星期一)在公司会议室以现场结合通讯的方式召开。全体 董事一致同意豁免本次会议通知期限要求。 本次会议应出席董事 9 人,实际出席董事 9 人。会议由董事长沈斌强先生主 持,监事、高管列席。本次会议召开符合有关法律、行政法规、部门规章、规范 性文件和《公司章程》的规定。 二、董事会会议审议情况 (一)逐项审议通过《关于进一步明确公司向不特定对象发行可转换公司 债券方案的议案》 公司已收到中国证券监督管理委员会出具的《关于同意江苏利柏特股份有限 公司向不特定对象发行可转换公司债券注册的批复》(证监许可[2025]1173 号), 同意公司向不特定对象发行可转换公司债券(以下简称"本次发行")的注册申 请。公司董事会根据 2024 年 ...
利柏特: 江苏利柏特股份有限公司股票交易异常波动公告
Zheng Quan Zhi Xing· 2025-06-20 09:32
证券代码:605167 证券简称:利柏特 公告编号:2025-019 江苏利柏特股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: ? 江苏利柏特股份有限公司(以下简称"公司")股票交易于 2025 年 6 月 根据《上海证券交易所交易规则》的有关规定,属于股票交易异常波动情形。 ? 经公司自查并向控股股东及实际控制人核实,截至本公告披露日,公司 不存在应披露而未披露的重大信息。 ? 二级市场交易风险:截至 2025 年 6 月 16 日,公司股票收盘价格为 13.18 元/股。根据中证指数有限公司发布的数据显示,公司所属的行业分类"E 建筑 业"最新市净率为 0.62 倍,公司最新市净率为 3.16 倍,高于同行业上市公司平 均水平。敬请广大投资者注意二级市场交易风险,理性决策,审慎投资。 一、股票交易异常波动的具体情况 公司股票交易于 2025 年 6 月 12 日、6 月 13 日、6 月 16 日连续三个交易日 内日收盘价格涨幅偏离值累计达 20%。根据《上海证券交易所交 ...
利柏特(605167) - 江苏利柏特股份有限公司股票交易异常波动公告
2025-06-16 10:31
江苏利柏特股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 江苏利柏特股份有限公司(以下简称"公司")股票交易于 2025 年 6 月 12 日、6 月 13 日、6 月 16 日连续三个交易日内日收盘价格涨幅偏离值累计达 20%。 根据《上海证券交易所交易规则》的有关规定,属于股票交易异常波动情形。 经公司自查并向控股股东及实际控制人核实,截至本公告披露日,公司 不存在应披露而未披露的重大信息。 二级市场交易风险:截至 2025 年 6 月 16 日,公司股票收盘价格为 13.18 元/股。根据中证指数有限公司发布的数据显示,公司所属的行业分类"E 建筑 业"最新市净率为 0.62 倍,公司最新市净率为 3.16 倍,高于同行业上市公司平 均水平。敬请广大投资者注意二级市场交易风险,理性决策,审慎投资。 生产经营风险:公司于 2025 年 4 月 30 日披露了《2025 年第一季度报告》, 2025 年第一季度公司实现归属于上市公司股东的净利润 35,866,613.96 ...
龙虎榜 利柏特上涨5.10%,知名游资海通总部卖出3440.71万元
Jin Rong Jie· 2025-06-16 09:27
6月16日,利柏特上涨5.10%登上龙虎榜,连续三个交易日内,涨幅偏离值累计达20%,知名游资卖出。 龙虎榜显示,买入前五合计买入1.96亿元,卖出前五合计卖出1.27亿元,净额6969.68万元。 买入金额最大的前5名营业部 买入额/万 卖出额/万 净额/万 瑞银证券有限责任公司上海浦东新区花园石 桥路第二证券营业部 5914.43 0.00 5914.43 国泰海通证券股份有限公司总部 4712.31 0.00 4712.31 中信证 券股份有限公司上海分公司 3247.03 0.00 3247.03 国投证券股份有限公司深圳安信金融大厦证券营业部 3153.27 0.00 3153.27 摩根大通证券(中国)有限公司上海银城中路证券营业部 2610.10 0.00 2610.1 卖出 金额最大的前5名营业部 买入额/万 卖出额/万 净额/万 国泰海通证券股份有限公司总部 0.00 3440.71 -3440.71 瑞银证券有限责任公司上海浦东新区花园石桥路第二证券营业部 0.00 2799.75 -2799.75 机构专 用 0.00 2557.36 -2557.36 高盛(中国)证券有限责任公司上海浦 ...
集体异动!核能领域,多则利好传来!
券商中国· 2025-06-12 15:42
Group 1: World Bank's Nuclear Energy Financing Policy - The World Bank has lifted a decades-long ban on nuclear energy financing to accelerate the development of low-emission technologies and meet the growing electricity demand in developing countries [2][3] - The World Bank plans to support efforts to extend the lifespan of existing nuclear reactors and assist in upgrading power grids and related infrastructure [3][4] - The bank aims to help develop small modular reactors, which are expected to be cheaper and faster to construct compared to traditional reactors [3][5] Group 2: Global Nuclear Fusion Developments - Proxima Fusion, a German nuclear fusion startup, has secured €130 million in funding, marking the largest investment in the European nuclear fusion sector to date [6][7] - The funding will be used to build a "stellarator model coil" by 2027, which is crucial for achieving key technological breakthroughs [7][8] - Proxima Fusion plans to construct a demonstration plant by 2031, with an estimated cost of €1 billion, and aims to partially secure funding from European governments [7][9] Group 3: Investment Opportunities in Nuclear Fusion - The global nuclear fusion policy trend is strengthening, with Japan advancing its fusion energy timeline from 2050 to 2030 [11] - Companies in the nuclear fusion sector are expected to benefit from ongoing technological advancements and supportive policies, creating investment opportunities across the entire industry chain [12] - The focus on high-barrier and high-value segments within the nuclear fusion supply chain is recommended for potential investment [12]
可控核聚变概念涨1.51%,主力资金净流入34股
Zheng Quan Shi Bao Wang· 2025-06-12 11:13
Group 1 - The controllable nuclear fusion concept has seen a rise of 1.51%, ranking 9th among concept sectors, with 44 stocks increasing in value [1] - Notable gainers in the controllable nuclear fusion sector include Rongfa Nuclear Power, Hongxun Technology, and Changfu Co., which saw increases of 10.04%, 9.99%, and 9.79% respectively [3][4] - The sector experienced a net inflow of 1.442 billion yuan, with 34 stocks receiving net inflows, and five stocks exceeding 50 million yuan in net inflow, led by Rongfa Nuclear Power with 937 million yuan [2][3] Group 2 - The top stocks by net inflow ratio include Hongxun Technology at 39.74%, Rongfa Nuclear Power at 29.99%, and Libat at 11.99% [3][4] - The overall market saw various concept sectors with mixed performance, with hair medical leading at 2.02% and the Korean Free Trade Zone declining by 1.52% [2] - Stocks such as Shun Sodium Co., Guoli Co., and Fuhuang Steel Structure faced declines of 3.53%, 3.44%, and 2.29% respectively [1][6]
6月11日晚间重要公告一览
Xi Niu Cai Jing· 2025-06-11 10:24
Group 1 - Libet has received approval from the China Securities Regulatory Commission for the issuance of convertible bonds, valid for 12 months [1] - Dinglong plans to acquire an additional 8% stake in its subsidiary, increasing its ownership from 91.35% to 99.35% for a total price of 240 million yuan [1] - Longyuan Donggu has been designated as a supplier for a major automotive project, with an expected total sales amount of 450 to 500 million yuan over five years [14] Group 2 - Luoniushan reported a sales revenue of 100 million yuan in May, a year-on-year decrease of 11.45% [2] - Baoming Technology has secured a loan commitment of up to 7 million yuan for stock repurchase [2] - Xinhua Pharmaceutical has received approval for the listing of a new chemical raw material used in treating chronic heart failure and hypertension [3] Group 3 - China Minmetals announced a new contract amount of 396 billion yuan for the first five months of the year, a decrease of 22.2% year-on-year [7] - Zhongbei Communication's application for a specific stock issuance has been accepted by the Shanghai Stock Exchange [8] - Rongfa Nuclear Power plans to issue bonds not exceeding 1 billion yuan to repay debts and supplement working capital [9] Group 4 - Phoenix Optical plans to invest 8.5 million USD to establish a wholly-owned subsidiary in Vietnam for manufacturing optical products [11] - Xiamen Airport reported a passenger throughput of 2.4752 million in May, a year-on-year increase of 8.34% [12] - Weilan Biological has received a new veterinary drug registration certificate for a product aimed at treating canine allergies and inflammation [13] Group 5 - Shouxiangu has completed the registration of a health food product that claims to enhance immunity [13] - Xingye Yinxin's subsidiary has passed a resource reserve verification report, confirming significant mineral reserves [16] - Shaanxi Construction has won two major projects with a total contract value exceeding 2.8 billion yuan [18] Group 6 - Huari received a cash dividend of 50 million yuan from its subsidiary [20] - Zhongchu's deputy general manager has resigned due to governance arrangements [21] - Kexin Pharmaceutical's core product has received breakthrough therapy designation from the National Medical Products Administration [39]
利柏特(605167) - 关于向不特定对象发行可转换公司债券申请获得中国证券监督管理委员会同意注册批复的公告
2025-06-11 09:47
证券代码:605167 证券简称:利柏特 公告编号:2025-018 江苏利柏特股份有限公司 关于向不特定对象发行可转换公司债券申请获得 中国证券监督管理委员会同意注册批复的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 江苏利柏特股份有限公司(以下简称"公司")于近日收到中国证券监督管 理委员会(以下简称"中国证监会")出具的《关于同意江苏利柏特股份有限公 司向不特定对象发行可转换公司债券注册的批复》(证监许可[2025]1173 号), 批复文件主要内容如下: 三、本批复自同意注册之日起 12 个月内有效。 四、自同意注册之日起至本次发行结束前,公司如发生重大事项,应及时报 告上海证券交易所并按有关规定处理。 公司董事会将按照上述批复文件和相关法律法规的要求以及公司股东会的 授权,在规定期限内办理本次向不特定对象发行可转换公司债券的相关事项,并 及时履行信息披露义务,敬请广大投资者注意投资风险。 特此公告。 江苏利柏特股份有限公司董事会 2025 年 6 月 12 日 一、同意公司向不特定对象发行可转换公司债券的注册 ...
天风证券晨会集萃-20250606
Tianfeng Securities· 2025-06-06 01:10
Group 1 - The report highlights the optimistic growth in the global power equipment market, projected to exceed $700 billion by 2025, with significant investments in the power grid expected to surpass $450 billion [3][23] - The company is positioned as a leader in the high-end diesel generator market, benefiting from strategic partnerships and a robust supply chain, which enhances its pricing power [3][24] - Revenue forecasts for the company indicate substantial growth, with expected revenues of 2.76 billion, 3.76 billion, and 4.75 billion yuan for 2025, 2026, and 2027 respectively, reflecting year-on-year increases of 689%, 36%, and 26% [3][24] Group 2 - The offshore wind power sector is anticipated to experience a new wave of growth, with domestic installations expected to reach 12 GW in 2025, a 200% increase year-on-year [4][6] - The company is expanding its production capacity and focusing on the deep-sea wind market, with significant investments in export terminals to meet growing international demand [4][6] - Profit forecasts for the company suggest net profits of 8.6 billion, 11.0 billion, and 13.1 billion yuan for 2025, 2026, and 2027, with corresponding price-to-earnings ratios of 15.8, 12.3, and 10.3 [4][6] Group 3 - The nuclear power sector is witnessing accelerated investment, with completed investments reaching 36.26 billion yuan in the first four months of 2025, a 36.64% year-on-year increase [12][27] - The company is well-positioned to capitalize on the modular construction market for nuclear power, with a projected market size of approximately 864 billion yuan from 2025 to 2030 [12][28] - Expected net profits for the company are projected to be 2.3 billion, 2.5 billion, and 2.9 billion yuan for 2025, 2026, and 2027, with price-to-earnings ratios of 20, 19, and 16 [12][30] Group 4 - The magnesium alloy market is experiencing rapid growth, with the company focusing on expanding its production capacity to meet increasing demand in various sectors, including aerospace and automotive [7][31] - Revenue for the company is expected to reach 4.09 billion yuan in 2024, reflecting a 16.01% year-on-year increase, with continued growth anticipated in subsequent years [7][31] - The company is actively integrating into the lightweight strategy of leading automotive manufacturers, enhancing its market position [7][31]